Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H2 2016
|
IMGN |
|
Phase 3 Results |
Oncology |
None |
|
H2 2016
|
ITCI |
|
Phase 3 Results |
Other |
None |
|
H2 2016
|
OXGN |
|
Phase 2 Results |
Oncology |
Orphan Drug |
|
H2 2016
|
NDRM |
|
Phase 2 Results |
Neurology |
None |
|
Q4 2016
|
PBYI |
|
Phase 2 Results |
Oncology |
None |
|
Q4 2016
|
RDHL |
|
Phase 2a Results |
Neurology |
None |
|
Q4 2016
|
ANTH |
|
Phase 3 Results |
Endocrine |
None |
|
Q4 2016
|
ATRS |
|
NDA Submission |
Endocrine |
None |
|
Q4 2016
|
CASC |
|
Phase 1b Results |
Oncology |
Fast Track |
|
Q4 2016
|
FLXN |
|
NDA Submission |
Other |
None |
|